Spatial proteomics maps early molecular changes in subchondral bone, offering potential biomarkers and reframing osteoarthritis as a whole-joint disease. We…
Biosplice submits NDA for lorecivivint, a potential first-of-its-kind therapy that aims to slow knee osteoarthritis itself. Osteoarthritis shapes how millions…
